Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer

por Kaufman, Bella, Stein, Steven, Casey, Michelle A, Newstat, Beth O
Publicado 2008

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

por Cameron, David, Casey, Michelle, Oliva, Cristina, Newstat, Beth, Imwalle, Bradley, Geyer, Charles E.
Publicado 2010

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

por Xu, Bing-He, Jiang, Ze-Fei, Chua, Daniel, Shao, Zhi-Min, Luo, Rong-Cheng, Wang, Xiao-Jia, Liu, Dong-Geng, Yeo, Winnie, Yu, Shi-Ying, Newstat, Beth, Preston, Alka, Martin, Anne-Marie, Chi, Hai-Dong, Wang, Li
Publicado 2011